Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement:
This continuing medical education activity is provided by 
.
Support Statement:
This activity is supported by educational grants from AbbVie, Inc., Actavis Laboratories, Inc., Prometheus Laboratories, Inc., and Shire.
Target Audience:
The intended audience for this activity is gastroenterologists, internal medicine physicians and other healthcare professionals involved in the treatment of patients with inflammatory bowel disease (IBD).
Learning Objectives:
At the conclusion of this activity, participants should be able to discuss the current pharmacological treatment options for ulcerative colitis.
Faculty:
Russell D. Cohen, MD, FACG, AGAF
Professor of Medicine, Pritzker School of Medicine
Co-Director, Inflammatory Bowel Disease Center
The University of Chicago Medicine
Chicago, IL
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, October 15, 2014, to October 14, 2015.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the presentation, complete the CME posttest, and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Faculty:
Russell D. Cohen, MD, FACG, AGAF
External Reviewers:
Ronald Codario, Jr., MD
Ronald Codario, MD, FACP, FNLA, CCMEP (Recertification review on October 7, 2014)
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
Faculty members report the following relationship(s), which are accurate at the time of original content release (November 23, 2013):
Russell D. Cohen, MD, FACG, AGAF
Consultant: Abbott Laboratories; Elan Pharmaceuticals, Inc.; Janssen (Johnson & Johnson/Centocor); Prometheus Laboratories Inc.; Salix Pharmaceuticals, Inc.; Santarus; UCB Pharma, Inc.; Warner Chilcott
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; Salix Pharmaceuticals, Inc.; Santarus
Received grants for clinical research from: UCB Pharma, Inc
Additional Disclosure: Spouse is currently Chief Commercial Officer at Medivation Inc.
External Reviewers report the following relationship(s):
Ronald Codario, Jr., MD
No relevant financial relationships to disclose.
Ronald Codario, MD, FACP, FNLA, CCMEP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement (for use in Enduring Materials):
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2014 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicomeded.com